Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2638-2639
doi: 10.1161/01.CIR.0000074240.87740.BE
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, T.
Right arrow Articles by Schneider, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, T.
Right arrow Articles by Schneider, M. D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Developmental biology
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrowRelated Article

(Circulation. 2003;107:2638.)
© 2003 American Heart Association, Inc.


Editorials

The Way to a Human’s Heart Is Through the Stomach

Visceral Endoderm-Like Cells Drive Human Embryonic Stem Cells to a Cardiac Fate

Teruya Nakamura, MD, PhD; Michael D. Schneider, MD

From the Center for Cardiovascular Development, Departments of Medicine, Molecular and Cellular Biology, and Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Tex.

Correspondence to Dr Michael D. Schneider, Center for Cardiovascular Development, Baylor College of Medicine, One Baylor Plaza, Rm 506D, Houston, TX 77030. E-mail michaels@bcm.tmc.edu


Key Words: Editorials • stem cells • cells, visceral • myocytes


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Heart failure due to myocardial infarction is the leading cause of morbidity and mortality in developed countries.1 While that point needs no reiteration for the Circulation audience, its corollary does: that heart failure, in essence, is a myocyte-deficiency disease. Cell death, whether from acute infarction alone or from sustained sporadic losses in chronic heart failure, is not matched by sufficient cell replacement. Adult cardiac muscle cells have long lost much if not all of their capacity for proliferative growth, and differences in interpretation hinge on shadings between "none" and "almost none."2,3 What cell replacement does occur occurs by other means, including the recruitment of undifferentiated progenitor cells—eg, from their niche in bone marrow through the circulation to the injured myocardium.4

See p 2733

Advances in fundamental molecular and cellular biology have paved the way for development of tissue engineering and regenerative medicine as a new therapeutic paradigm, in effect, the Regeneration Superhighway. Among such advances, so-called stem cells have been greeted with greatest enthusiasm, as well as religious and political alarm. Replacing dead cardiac muscle cells with living ones to preserve pump function is a goal of indisputable merit. But which cells have this capacity to transform from something that isn’t a cardiac myocyte into something that is? Among the potential sources, why has controversy arisen for some? Which can be propagated and expanded best in tissue culture? How faithful is their differentiation, compared with "real" cardiac muscle cells? And, what governs their conversion?

The concept of "stemness" embraces two . . . [Full Text of this Article]


Related Article:

Differentiation of Human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells
Christine Mummery, Dorien Ward-van Oostwaard, Pieter Doevendans, Rene Spijker, Stieneke van den Brink, Rutger Hassink, Marcel van der Heyden, Tobias Opthof, Martin Pera, Aart Brutel de la Riviere, Robert Passier, and Leon Tertoolen
Circulation 2003 107: 2733-2740. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
P. Anversa, J. Kajstura, A. Leri, and R. Bolli
Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology
Circulation, March 21, 2006; 113(11): 1451 - 1463.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Leri, J. Kajstura, and P. Anversa
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
Physiol Rev, October 1, 2005; 85(4): 1373 - 1416.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Anversa, J. Kajstura, and A. Leri
Circulating Progenitor Cells: Search for an Identity
Circulation, November 16, 2004; 110(20): 3158 - 3160.
[Full Text] [PDF]